Related Experiment Video
Updated: Jun 12, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sarcomere gene mutations in hypertrophy and heart failure
Hiroyuki Morita1, Ryozo Nagai, J G Seidman
1Department of Translational Research for Healthcare and Clinical Science, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Journal of Cardiovascular Translational Research
|June 19, 2010
Summary
Genetic mutations linked to hypertrophic cardiomyopathy may also increase heart failure risk. Genetic testing could identify at-risk individuals, potentially reducing heart failure incidence.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Heart failure is a growing cardiovascular disease problem despite advances in risk factor management.
- Hypertrophic remodeling, a common response to cardiovascular disorders, elevates heart failure risk.
- Genetic basis of hypertrophic cardiomyopathy is increasingly understood.
Purpose of the Study:
- To investigate if genes causing hypertrophic cardiomyopathy contribute to pathological remodeling in acquired cardiovascular disorders.
- To explore the potential of genetic testing for identifying individuals at risk of heart failure.
Main Methods:
- Review of recent studies identifying sarcomere protein mutations and sequence variants.
- Analysis of genetic data in community-based populations with hypertrophy and heart failure.
Main Results:
- Evidence suggests a shared etiology between hypertrophic cardiomyopathy genes and acquired cardiovascular disorders leading to heart failure.
- Sarcomere protein mutations and variants are found in populations with hypertrophy and heart failure.
Conclusions:
- Genetic testing for hypertrophic mutations may identify patients at risk for heart failure.
- Understanding hypertrophic remodeling mechanisms can inform strategies to prevent heart failure.
- Targeting genetic factors could reduce the overall burden of heart failure.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
01:08The Sarcomere
A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each myosin...
Each myosin...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...